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Approaches to identify extracellular receptor–ligand
interactions
Laura Wood and Gavin J Wright
Thousands of secreted factors and plasma membrane-
associated cell surface receptors are categorised into families
that vary widely in their structures and functions. They often
participate in extracellular binding events, but due to their
unique physicochemical properties, their interactions are
challenging to study. As lists of extracellular proteins become
more complete and accurate, new methodologies are being
developed to systematically identify how these proteins
interact. Two main approaches have been used: direct binding
between recombinant soluble receptor ectodomains and cell-
based assays. Recent advances in chemoproteomic reagents,
cDNA overexpression, and cell-based genetic approaches
promote the identification of extracellular protein–protein
interactions within the context of an intact plasma membrane in
living cells and opens up the discovery of cell surface
recognition events that were previously intractable.
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Introduction
Multicellular organisms are composed of many different
cell types that co-ordinate their activities to form and
maintain complex biological structures such as tissues
and organs. As discrete units, cells must be able to recognise
local cues and activate signalling pathways to alter cell
behaviour in accordance with their immediate surround-
ings. To accomplish this, an array of structurally varied
protein receptors embedded within the semi-permeable
lipid bilayer of the plasma membrane serve as an interface
between the external space and cell interior. These mole-
cules usually require an N-terminal signal peptide for
transport to the cell surface and can be tethered to the outer
membrane through a glycosylphosphatidylinositol (GPI)-
lipid modification, or contain one or more transmembrane
domains. Regions that project out into the extracellular
space are capable of binding soluble secreted factors or cell
surface ligands exposed on adjacent cells and receptors that
span the plasma membrane can relay instructional informa-
tion to the cytoplasm to activate cell responses such as
migration, differentiation, proliferation, cell growth and
apoptosis. Cell surface receptor–ligand binding between
cells (trans-interactions) are essential regulatory events
coordinating many developmental and biological processes,
and aberrant loss or gain of extracellular recognition can
contribute to inappropriate changes in cell behaviour (e.g.
cancer metastasis [1]). Receptors are also at the centre of
host-pathogen interactions where protein binding is essen-
tial for influencing the pathology of infection which confers
a major public health risk in relation to emerging diseases,
most significantly by determining host tropism [2]. Motiva-
tions to study extracellular interactions are driven, not only
by their wide ranging implications in development and
disease, but also due to their accessibility to systematically
delivered therapeutics, making these class of interactions
tractabledrug and vaccine targets.Currently70%ofFDA-
approved drugs target proteins containing transmembrane
domains and/or signal peptides [3,4].
The unique biophysical properties of secreted and mem-
brane spanning receptors make them a difficult subset of
proteins to study. Firstly, oxidising environments, such as
those found in the extracellular space, are required for
disulphide bond formation between cysteine residues
which are required for correct folding of protein ectodo-
mains. Secondly, without an intact plasma membrane,
solubilisation of full length functional receptors can be
difficult to achieve. This is due to the amphipathic nature
of transmembrane proteins which often contain both
hydrophilic glycans, as well as stretches of hydrophobic
amino acids which span the membrane. Finally, recogni-
tion events involving cell surface receptors are frequently
low affinity (KDs in mM–mM range) and usually require
localised clustering within the plasma membrane to
increase binding avidity [5]. Physiologically, this means
that protein–protein interactions can be easily reversed,
allowing the cell to react quickly to continual changes in
surrounding stimuli. Biochemically, this presents chal-
lenges and monovalent binding events with fast dissocia-
tion rates may not be detected with many high-through-
put methods [5,6]. Certainly, interactions involving
extracellular proteins were found to be underrepresented
in commonly used protein–protein interaction screens
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(e.g. Yeast-2-Hybrid (Y2H), Mammalian Protein–Protein
Interaction Trap (MAPPIT), LUminescence-based
Mammalian IntERactome (LUMIER)) [7] and binding
events with proteins containing transmembrane helices or
hydrophobic regions are also depleted in larger Y2H and
co-fractionation studies [8]. Systematic interactome maps
employing affinity purification–mass spectrometry (AP–
MS) of stably expressed bait proteins do appear to iden-
tify plasma membrane binding partners, but whether
these interactions represent trans-interactions on the cell
surface is not clear [9,10].
Recent efforts to better classify the extracellular inter-
actome (‘secretome’ and ‘surfaceome’) highlights the
potential complexity of this interaction network [3,11–
13]. Factors that are secreted into the extracellular space
are predicted to form 15% of the human proteome
based on computational models to identify proteins
containing signal peptides, but lacking transmembrane
domains [3]. Similarly, the surfaceome is comprised of
thousands of proteins with 1492 glycoproteins across
41 human cell lines accessible to chemoproteomic cap-
ture on the cell surface [12], while >1700 proteins have
been confirmed to localise at plasma membranes based
on immunocytochemistry observations [3,11]. Here, we
aim to review some of the key methods used to system-
atically identify interactions between these groups of
proteins. Particular emphasis has been placed on recent
approaches that- first, take account of the biochemical
challenges described above in identifying trans-interac-
tions and second, have the potential to be developed, or
are currently being applied, as high-throughput techni-
ques. We discuss two broad experimental platforms: the
use of heterologous expression systems in the production
of large recombinant protein libraries consisting of solu-
ble receptor ectodomains and approaches that use living
cells to study cell surface interactions within the physi-
ologically relevant microenvironment of the plasma
membrane.
High-throughput detection: recombinant
protein libraries
An important discovery in the development of high-
throughput assays to detect cell surface interactions is
that receptor ectodomains, when expressed as soluble
recombinant proteins, can retain ligand binding func-
tions [5,6]. Using mammalian and insect cell lines,
recombinant proteins can be processed with appropri-
ate post-translational modifications, including glycans
and disulphide bonds, which are often critical for cor-
rect folding. Most methods utilise a ‘prey’ and ‘bait’
approach whereby ectodomains are immobilised on a
solid surface and systematically probed for direct inter-
actions with another recombinant protein (Figure 1)
[14–18]. Multimerisation of proteins is an important
step in this process as it functions to increase the
binding avidities of transient interactions and occurs
in two formats: localised conjugation in a microtitre well
(baits) or using an oligomerisation tag (preys). This
method has successfully discovered many ligand–
receptor interactions, such as those essential for mero-
zoite invasion of erythrocytes [19], neural guidance and
interconnectivity [15,17], and studies focused within
defined protein families [16,20]. More recently, this
technique has been used for the first time to screen a
library of single pass transmembrane receptor ectodo-
mains (1300) against recombinantly produced viral
envelope proteins [21]. By taking advantage of differ-
ent multimerisation tags, Martinez-Martin et al. were
able to produce trimers and pentamers of distinct
glycoproteins found on the surface of the human
cyto-megalovirus (HCMV) and found non-overlapping
receptor binding partners for the two HCMV com-
plexes. Of these, NRP2, a novel binding partner of
the pentameric complex, was shown to play an impor-
tant role in HCMV infection of epithelial and endothe-
lial cells [21].
Protein production is resource intensive and many
studies limit the number of soluble ectodomains by
concentrating on a subset of proteins, such as surface
receptors expressed on a specific cell type (e.g. ery-
throcytes, platelets). To expand the number of proteins
tested and reduce the amount of material required for
each interaction assay, microarray technology enables
the spotting of thousands of recombinant extracellular
domains on a single slide and fluorescence signals,
rather than enzymatic reactions, can be used to map
protein–protein binding events (Figure 1) [22,23].
The largest of these screened 40 500 binary events
and identified 51 novel interactions between human
receptors and an immunomodulatory protein on ade-
novirus family members [23]. This methodology also
has its problems, with potential issues in printing
reproducibility between slides and long print runs that
may compromise protein functionality if not main-
tained at low temperatures. Nucleic Acid Programma-
ble Arrays (NAPPA) support an alternative microarray
format whereby printed complementary DNAs
(cDNAs) can be transcribed and translated in vitro
directly on slides, and therefore eliminates the need
for resource intensive protein purifications [24,25].
Combined with a microfluidic platform, Glick et al.,
was able to utilise this technology to create arrays of
2100 human membrane proteins and could success-
fully identify virus-receptor interactions [26]. As this is
a cell-free system, it is still unclear as to what extent
missing post-translation modifications and incorrect
folding may affect receptor binding properties across
the library.
The major drawback of recombinant expression libraries
is that they only work for ectodomains that can be
functionally expressed as a single contiguous region,
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including type I and type II single pass transmembrane
proteins, GPI anchored proteins and secreted polypep-
tides. Multi-pass membrane proteins and co-factor com-
plexes are usually excluded from these expression lists,
although integrin receptor combinations do appear to
maintain binding specificities when co-expressed as a
and b subunits [27]. In addition to this, large recombinant
protein libraries are beyond the scope of many laborato-
ries that may only be interested in identifying the inter-
action partners for one or a small group of proteins. Cell-
based assays can serve as an alternative approach by
simply using the endogenous receptor repertoire as an
existing bait library, or utilising the cell machinery to
exogenously overexpress cell surface proteins. Provided
the plasma membrane remains intact, this can function as
a platform to study cell surface recognition events that
were previously biochemically intractable.
High-throughput detection: cell-based assays
Ligand-receptor capture proteomics
Advances in mass spectrometry sensitivity and quan-
titation, together with improved isolation techniques,
have been instrumental in the identification of large
protein interactomes from complex mixtures (e.g.
crude cell extracts) [9,10,28]. To gain access to the
internal cell proteome, plasma membranes must be
disrupted. In some instances, this can lead to non-
functional receptors since membrane-spanning poly-
peptides may no longer be able to maintain their
native conformation. Larger insoluble plasma mem-
brane fragments may also pellet during early isolation
steps, causing membrane-associated proteins to be
depleted from downstream analysis. Although classical
AP–MS studies have had success in identifying host
receptors for a number of virus glycoproteins, includ-
ing HCMV and Herpes simplex virus (HSV) [29,30],
extracellular protein interactions can be transient in
nature (t1/2 <1 s) [5] and washes containing salts and
detergents to remove non-specific binders may also
exclude weak cell surface interactions. To overcome
these challenges, the Wollscheid group synthesised a
trifunctional compound (TRICEPS) that utilises the
glycan rich coat displayed by many cell surface pro-
teins to capture receptor interactions on intact living
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Extracellular protein interaction screening using soluble recombinant ectodomains.
Secreted factors, GPI anchored proteins and the ectodomains of single-pass transmembrane receptors can be expressed in heterologous
expression systems where they are released into the cell media and either used directly in supernatants or concentrated with purification tags.
Screening usually requires two protein libraries: a bait (A–C) and a prey (1–3). Prey recombinant proteins are typically oligomerised using a tag
that promotes spontaneous multimerisation (e.g. dimers, trimers, pentamers), while bait proteins are conjugated to a solid substrate. In this
schematic, bait proteins have been tagged with biotin and bound to a streptavidin coated surface, although other methods have been used
[16,18]. In well-based detection, baits and preys are systematically screened against one another to account for all pairwise interactions. Prey
proteins are fused with enzymatic reporter molecules so that binding to the bait library can be assessed using colorimetric measurement changes
after substrate addition. Microarray technology is capable of spotting large recombinant bait libraries in a defined layout onto treated slides.
Protein A microbeads coated with an unlabelled Fc-fusion prey protein and Cy5-labelled IgG can then be used to map extracellular interactions
using localised fluorescence signals imaged using a microarray scanner [22,23]. Binding to the arrayed bait library can also be detected using
fluorescently labelled antibodies against a specific tag on the prey [65].
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cells [31,32]. TRICEPS is covalently conjugated to the
primary amines of a ligand of interest, while a second
functional group facilitates crosslinking to glycosy-
lated binding partners on the surface of cells cultured
in an oxidising environment. A final biotin group is
bound by streptavidin for the affinity purification of
peptides containing N-glycosylation motifs, and gly-
can cleavage followed by mass spectrometry analysis
reveals enriched ligand interactors. Secreted proteins,
therapeutic antibodies, peptides and virus particles
were all shown to act as successful probes in the
capture of known cell surface recognition events
[31]. Notably, they were able to verify binding of a
peptide (apelin-17) with its target G-protein-coupled
receptor (Apelin receptor), highlighting that protein
interactions with multi-spanning cell surface receptors
can indeed be identified by techniques that take into
account the integrity of the cell membrane. Further
development of this concept has led to the creation of
a trifunctional crosslinker called ASB (aldehyde-reac-
tive aminooxy group, a sulfhydryl, and a biotin) [33]
and more recently HATRIC-based ligand receptor
capture (HATRIC-LRC) [34]. In the latter, experi-
ments can be performed in a physiologically relevant
environment (pH 7.4), opening up the discovery to
pH-sensitive cell surface interactions. The use of
azide click chemistry to label glycoproteins for affinity
isolation also means that peptides within the full
length protein can be used for mass spectrometry
identification (not just N-glycosylated peptides)
reducing the need for large amounts of starting mate-
rial—an important technical consideration for cell
lines that are difficult to grow in culture [34].
Although TRICEPS, ASB and HATRIC possess many
advantages when it comes to studying receptor  bind-
ing events in their natural states, components of the
cell surface must be glycosylated and therefore a
subset of glycan-free proteins may be missing from
these interaction lists.
Expression cloning using cDNA expression libraries
In expression cloning, a library of complementary DNAs
(cDNAs) is transfected into cultured cell lines and
screened for a phenotype of interest. Multiple subdivid-
ing rounds filter ‘positive’ and ‘negative’ cDNA pools
until a single expression plasmid is recovered [35]. In
regards to extracellular interactions, a common readout
would be cells that have gained the ability to bind a
recombinant ligand of interest. In the past this technique
was crucial in the discovery of a number of growth factor
receptors [36–38]. Adapted protocols have been used to
identify interactions between Hepatitis C virus and
multi-spanning transmembrane proteins CD81 [39],
Claudin-1 [40] and Occludin [41] and more recently
the low affinity binding (KD of 12 mM) between egg
and sperm surface proteins during fertilisation [42]. In
recent years, genome sequencing and gene annotation
have enabled projects such as the Mammalian Gene
Collection [43] and the Orfeome collaboration [44] to
compile sequence-verified plasmid libraries. This inno-
vation supports the replacement of pooled approaches
with individual cDNA transfections as it eliminates the
need for iterative rounds of selection and instead reveals
an immediate binary interaction (Figure 2). As an exam-
ple, Lin et al. expressed 400 surface receptors in COS7
cells and probed with a similar library of ectodomain-Fc
fusions reporting a single positive hit, the Netrin-G1 and
NGL-1 interaction [45]. Recent efforts to make this more
high-throughput have seen this technique develop into a
‘microarray’-based screen. The Sabatini group first
showed that spotted cDNAs (120–150 mm in diameter)
could be ‘reverse transfected’ into HEK293T cells grown
over the top of slides, with subsequent protein expression
only seen in localised areas where cells had come in direct
contact with the patterned plasmids [46]. Large libraries
of expression plasmids encoding for full length plasma
membrane receptors can be arrayed on slides, reverse
transfected into cells, and the overexpressed receptors
used as a surface to probe for extracellular interactions
(Figure 2). EMP1, a Plasmodium falciparum (Pf) protein
exposed on infected erythrocytes, was shown to bind to
cells locally overexpressing the endothelial protein C
receptor (EPCR) using a commercially available adaption
of this technology [47]. Thousands of interactions can be
probed in a single experiment, with the most recent
attempts screening 3559 and 4493 cell surface proteins
against Hom-1 virus particles [48] and a recombinant
growth factor (GDF15) [49], respectively.
CRISPR and haploid genetic screens
CRISPR/Cas9 technology and haploid genetic screens
allow genome scale study of loss of function phenotypes
[50–53]. In the pooled CRISPR/Cas9 approach, a library
of guide RNAs are targeted to essentially all protein-
coding genes within the genome so that libraries of cells,
each deficient in a non-essential gene, can be created
[50,51]. In haploid cell screens, retroviral gene-traps
integrate into the genome and inactivate single alleles
through insertional mutagenesis [52,53]. By selecting for
cell populations that are refractory to pathogen infection,
these gene disruption techniques have been particularly
successful in the discovery of virus-host cell entry factors
[54]. Known virus recognition events with human cell
surface receptors have been corroborated using both
CRISPR and haploid genetic screens: Hepatitis C Virus
(Occludin, CD81, Claudin-1 [55]), Zika virus (AXL [56]),
HIV (CD4 and CCR5 [57]), Poliovirus (PVR [58]) and
Coxsackie virus B1 (CXADR [58]) and these approaches
have also been used to identify novel host receptors for
viruses [59–62,63].
Fluorescently conjugated protein extracellular domains
that bind to endogenous receptors on the surface of cells
can be used as an effective marker during fluorescence-
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activated cell sorting (FACS) [64]. By selecting cells
that exhibit a ‘loss of binding’ phenotype seven low
affinity ligand–receptor interactions, and a novel binding
event, were reported using pooled CRISPR/Cas9 tech-
nology. Multi-pass transmembrane proteins were discov-
ered in two instances; first as a direct receptor for Syncy-
tin-1, and second as a cell surface chaperone for basigin,
the receptor of PfRH5. The latter highlights one of the
main advantages of this technique—the ability to explore
contributions from genes in pathways critical for receptor
presentation on the cell surface–and includes compo-
nents such as transcription factors, trafficking proteins
and post-translational modification enzymes. For exam-
ple, CD59 surface detection with an antibody was found
to depend on GPI anchor biosynthesis pathway compo-
nents [64], while plasma membrane localisation of
CCR5, an essential receptor for HIV infection, requires
factors that attach sulfates to key tyrosine residues [57].
Genome-wide approaches can also be used to identify
complex carbohydrate-based receptors, such as surface
displayed heparan sulfates. When evaluating genes
responsible for loss of PfRH5 cell binding, both basigin
and heparan biosynthesis components were identified as
high confidence hits [64]. A protein receptor containing
immunoglobulin-like domains and heparan biosynthesis
enzymes were also enriched in genetic screens studying
adeno-associated virus infection [61] and highlights that
multiple cell surface receptors can be detected in a single
screen and these can be protein or non-protein-based
molecules. Therefore, a crucial advantage of this tech-
nique is that no prior assumptions need to be made
regarding the molecular nature of the receptors involved.
Conclusions and perspectives
In this review, we present an overview of the latest high-
throughput techniques used to study extracellular
protein–protein interactions. Although efforts have been
made to identify genes that encode proteins destined for
the cell surface or extracellular space, a definitive list that
takes into account the localisation patterns of canonical
and alternatively spliced isoforms, as well as genetic
variants, is currently not complete. This level of com-
plexity is a major research challenge and even if full
coverage of the extracellular proteome is achieved, any
one method is unlikely to detect all interaction networks
since each have their own advantages and disadvantages
(Table 1). With the dropping costs of gene synthesis and
improved yields in heterologous protein expression sys-
tems, producing large recombinant libraries is not as
daunting as it once was; however, the technique is still
limited by its inability to identify receptor interactions
involving multiple co-factors. Cell-based assays provide
an opportunity to bridge this gap by ensuring that protein
interactions are studied on intact cell surfaces. In genome
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Extracellular protein interaction screens using cDNA transfection protocols. cDNAs encoding full length receptors are introduced into cells using
commercially available transfection reagents. The cell utilises its own machinery to overexpress receptors on the cell surface and this in turn is
used as a platform to study extracellular protein–protein interactions with ligands such as recombinant protein ectodomains and virus particles. In
well-based detection, cDNAs are transfected individually into cells grown in microtitre wells (A–C). Prey recombinant proteins (1–3) are then
incubated with cells and interactions detected using fluorescently labelled antibodies and fluorescence microscopy imaging. Alternatively, cDNAs
can be spotted onto slides with a microarrayer and reverse transfected into a lawn of cells. Cells that locally take up cDNAs will express the
specific receptors on their cell surface and detection of extracellular interactions can be mapped using fluorescent antibodies against a specific
tag on the recombinant prey.
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wide genetic screens, the use of intact living cells enables
a phenotype-driven approach for evaluating protein bind-
ing events, and may have a greater potential for revealing
physiologically relevant interactions, such as those
described for virus infection models. One of the most
interesting outcomes is that genome wide loss-of-func-
tion screens can identify, not only direct ligand binding
partners, but also upstream pathways critical for receptor
presentation on the cell surface. Highlighting multiple
targets at different points along the same pathway is likely
to be helpful in drug discovery pipelines. All of these
methods have the ability to uncover independent and
overlapping protein binding events and this is deter-
mined, in part, by the biochemical nature of the receptor
in question. With the potential for increased scalability
and sensitivity, integration of these interaction networks
will be necessary for the construction of a comprehensive
and accurate map of the extracellular interactome.
Extracellular protein interactions Wood and Wright 33
Table 1
Advantages and disadvantages of extracellular protein–protein interaction screens
Biochemical assays Cell-based assays
Recombinant protein production Chemoproteomic
reagents
cDNA expression
libraries
Genome wide loss-of-function
screens
Advantages Ectodomains from secreted
factors, single-pass and GPI
linked proteins can be
expressed and solubilised
Potential to identify
interactions with
endogenously expressed
single-pass, GPI linked,
multi-pass and multi-
subunit receptors
Potential to identify
interactions with
overexpressed single-pass,
GPI linked, multi-pass and
multi-subunit receptors
Potential to identify interactions
with protein receptors, non-
protein receptors (e.g. Heparan
sulfate) and upstream pathway
components
Suitable post-translational
modifications may increase the
likelihood of correct folding
Full length functional
receptors are studied
within the context of the
cell surface
microenvironment
Full length functional
receptors are studied within
the context of the cell
membrane, although the
surface microenvironment is
altered due to forced
overexpression of a receptor
Full length functional receptors
are studied within the context of
the cell surface
microenvironment
Multimerisation strategies
increase the binding avidity of
low affinity cell surface
interactions
Variety of ligands can be
used to probe cell
surface interactions—
peptides, viruses,
proteins
Variety of ligands can be
used to probe cell surface
interactions— proteins,
viruses
Variety of ligands can be used to
probe cell surface interactions
and the readout is phenotype
driven. Can study processes
such as pathogen invasion and
cell survival
Recombinant proteins can be
concentrated using purification
tags and protein activities
normalised for robust readouts
in downstream assays
HATRIC-LRC: Can
detect pH sensitive
interactions and requires
low amounts of starting
material
Sequence validated Open
reading frame (ORF)
expression clones are readily
available. cDNA libraries are
stable and can be frozen for
long term storage
No prior assumptions on the
nature of the receptor need to be
made
Disadvantages Post-translational modifications
may be missed (e.g. under
glycosylated).
A fraction of the protein may be
misfolded.
Depends on the
endogenous levels of a
receptor. Non-
expressing or low
abundance receptors
may be missed
Depends on the cell’s ability
to overexpress and transport
receptors to the cell surface
Depends on the endogenous
levels of a receptor. Non-
expressing or low abundance
receptors may be missed
Protein production is costly and
resource intensive. Low
expressers can be difficult to
obtain in sufficient amounts.
Requires receptor to be
glycosylated
High numbers of transient
transfections performed for
every individual screen.
Potential variation in
transfection efficiency
Difficult to identify essential
genes as the cells with mutations
in these genes are likely to drop
out of the population causing
under sampling
Long-term storage difficult—
multiple freeze–thaws may
cause protein denaturation
Amine conjugation may
mask ligand binding sites
(e.g. protein binding
domains containing
lysine residues)
Large cDNA libraries can be
difficult to compile and
organise.
The use of loss-of-function
approaches makes it difficult to
identify functionally redundant
receptors
Multi-pass membrane proteins
and multi-subunit receptors are
often biochemically intractable
Mild chemical oxidation
of living cells may inhibit
some cell surface
interactions
Co-transfection probably
limited to multi-subunit
complexes with 2–3
components
Large numbers of cells are
required for statistically
significant results. This leads to
long cell sorting times, reducing
the throughput of interaction
screens
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